This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2018 Aug 16;379(7):655-668.

doi: 10.1056/NEJMra1710575.

Clinical Course and Management of Hypertrophic Cardiomyopathy

Barry J Maron¹

Affiliations

PMID: 30110588
DOI: 10.1056/NEJMra1710575

Review

Clinical Course and Management of Hypertrophic Cardiomyopathy

Barry J Maron. N Engl J Med. 2018.

. 2018 Aug 16;379(7):655-668.

doi: 10.1056/NEJMra1710575.

Author

Barry J Maron¹

Affiliation

¹ From the Hypertrophic Cardiomyopathy Center and Research Institute, Tufts Medical Center, Boston.

PMID: 30110588
DOI: 10.1056/NEJMra1710575

No abstract available

PubMed Disclaimer

Comment in

Clinical Course and Management of Hypertrophic Cardiomyopathy.
Bachmayer K. Bachmayer K. N Engl J Med. 2018 Nov 15;379(20):1976. doi: 10.1056/NEJMc1812159. N Engl J Med. 2018. PMID: 30440114 No abstract available.
Clinical Course and Management of Hypertrophic Cardiomyopathy.
Pascoe SJ. Pascoe SJ. N Engl J Med. 2018 Nov 15;379(20):1976-7. doi: 10.1056/NEJMc1812159. N Engl J Med. 2018. PMID: 30440115 No abstract available.

Similar articles

The management of hypertrophic cardiomyopathy.
Spirito P, Seidman CE, McKenna WJ, Maron BJ. Spirito P, et al. N Engl J Med. 1997 Mar 13;336(11):775-85. doi: 10.1056/NEJM199703133361107. N Engl J Med. 1997. PMID: 9052657 Review. No abstract available.
Myocardial disease: The patient with hypertrophic cardiomyopathy.
ten Berg J, Steggerda RC, Siebelink HM. ten Berg J, et al. Heart. 2010 Nov;96(21):1764-72. doi: 10.1136/hrt.2009.190124. Heart. 2010. PMID: 20956494 No abstract available.
Advances in understanding hypertrophic cardiomyopathy.
Mohiddin S, Fananapazir L. Mohiddin S, et al. Hosp Pract (1995). 2001 May 15;36(5):23-5, 29-30, 33-6. doi: 10.3810/hp.2001.05.236. Hosp Pract (1995). 2001. PMID: 11361156 No abstract available.
Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
Limongelli G, Elliott PM, Pacileo G, Sarubbi B, Thaman R, Calabrò P, Vergara P, Iacomino M, Russo MG, Calabrò R. Limongelli G, et al. J Cardiovasc Med (Hagerstown). 2006 Sep;7(9):711-3. doi: 10.2459/01.JCM.0000243007.97793.0f. J Cardiovasc Med (Hagerstown). 2006. PMID: 16932087
Misconceptions and Facts About Hypertrophic Cardiomyopathy.
Argulian E, Sherrid MV, Messerli FH. Argulian E, et al. Am J Med. 2016 Feb;129(2):148-52. doi: 10.1016/j.amjmed.2015.07.035. Epub 2015 Aug 20. Am J Med. 2016. PMID: 26299316 Review.

See all similar articles

Cited by

Metabolic characterization of hypertrophic cardiomyopathy in human heart.
Wang W, Wang J, Yao K, Wang S, Nie M, Zhao Y, Wang B, Pang H, Xu J, Wu G, Lu M, Tang N, Qi C, Pei H, Luo X, Li D, Yang T, Sun Q, Wei X, Li Y, Jiang D, Li P, Song L, Hu Z. Wang W, et al. Nat Cardiovasc Res. 2022 May;1(5):445-461. doi: 10.1038/s44161-022-00057-1. Epub 2022 May 9. Nat Cardiovasc Res. 2022. PMID: 39195941
Mavacamten: A First-in-class Oral Modulator of Cardiac Myosin for the Treatment of Symptomatic Hypertrophic Obstructive Cardiomyopathy.
Reyes KRL, Bilgili G, Rader F. Reyes KRL, et al. Heart Int. 2022 Oct 5;16(2):91-98. doi: 10.17925/HI.2022.16.2.91. eCollection 2022. Heart Int. 2022. PMID: 36741099 Free PMC article. Review.
Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy.
Rowin EJ, Maron MS, Wells S, Patel PP, Koethe BC, Maron BJ. Rowin EJ, et al. J Am Heart Assoc. 2019 Nov 5;8(21):e012041. doi: 10.1161/JAHA.119.012041. Epub 2019 Oct 30. J Am Heart Assoc. 2019. PMID: 31663408 Free PMC article.
Sex differences in atrial remodeling and its relationship with myocardial fibrosis in hypertrophic obstructive cardiomyopathy.
Bi X, Song Y, Yang C, Song Y, Zhao S, Qiao S, Zhang J. Bi X, et al. Front Cardiovasc Med. 2022 Nov 30;9:947975. doi: 10.3389/fcvm.2022.947975. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36531728 Free PMC article.
Relation between lymphocyte to monocyte ratio and survival in patients with hypertrophic cardiomyopathy: a retrospective cohort study.
Chen Z, Wang Z, Li Y, Chen X, He S. Chen Z, et al. PeerJ. 2022 Mar 29;10:e13212. doi: 10.7717/peerj.13212. eCollection 2022. PeerJ. 2022. PMID: 35368342 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- ClinicalTrials.gov